Technical Analysis for AKBA - Akebia Therapeutics, Inc.

Grade Last Price % Change Price Change
grade C 4.05 -4.93% -0.21
AKBA closed down 4.93 percent on Friday, August 23, 2019, on 83 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical AKBA trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup -4.93%
Wide Bands Range Expansion -4.93%
Down 3 Days in a Row Weakness -4.93%
Stochastic Sell Signal Bearish -8.58%
Wide Bands Range Expansion -8.58%

Older signals for AKBA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Akebia Therapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of proprietary therapeutics based on hypoxia inducible factor (HIF) biology for patients with kidney disease. Its lead product candidate is AKB-6548, a HIF-PH inhibitor, which is in Phase IIb clinical trials for patients with anemia secondary to chronic kidney disease who are not dependent on dialysis. The company is also developing a development program for patients dependent on dialysis. Akebia Therapeutics, Inc. was founded in 2007 and is headquartered in Cambridge, Massachusetts.
Biopharmaceutical Dialysis Chronic Kidney Disease Anemia Kidney Kidney Disease Hypoxia Inducible Factors
Is AKBA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 10.45
52 Week Low 3.5
Average Volume 1,027,140
200-Day Moving Average 6.0807
50-Day Moving Average 4.2414
20-Day Moving Average 4.216
10-Day Moving Average 4.436
Average True Range 0.2926
ADX 20.76
+DI 23.2809
-DI 25.0684
Chandelier Exit (Long, 3 ATRs ) 4.0022
Chandelier Exit (Short, 3 ATRs ) 4.3778
Upper Bollinger Band 4.8781
Lower Bollinger Band 3.5539
Percent B (%b) 0.37
BandWidth 31.408918
MACD Line 0.0499
MACD Signal Line 0.0422
MACD Histogram 0.0077
Fundamentals Value
Market Cap 74.12 Million
Num Shares 18.3 Million
EPS -3.60
Price-to-Earnings (P/E) Ratio -1.13
Price-to-Sales 6.10
Price-to-Book 12.65
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.59
Resistance 3 (R3) 4.64 4.51 4.50
Resistance 2 (R2) 4.51 4.37 4.49 4.47
Resistance 1 (R1) 4.28 4.29 4.22 4.23 4.44
Pivot Point 4.15 4.15 4.12 4.13 4.15
Support 1 (S1) 3.92 4.01 3.86 3.87 3.66
Support 2 (S2) 3.79 3.93 3.77 3.63
Support 3 (S3) 3.56 3.79 3.60
Support 4 (S4) 3.51